|
1
|
Zhang JP, Yan J, Xu J, Pang XH, Chen MS,
Li L, Wu C, Li SP and Zheng L: Increased intratumoral
IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Srivatanakul P, Sriplung H and Deerasamee
S: Epidemiology of liver cancer: An overview. Asian Pac J Cancer
Prev. 5:118–125. 2004.PubMed/NCBI
|
|
3
|
Ferenci P, Fried M, Labrecque D, Bruix J,
Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo JA,
et al: Hepatocellular carcinoma (HCC): A global perspective. J Clin
Gastroenterol. 44:239–245. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Villanueva A and Llovet JM: Targeted
therapies for hepatocellular carcinoma. Gastroenterology.
140:1410–1426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun Y and Peng Z: Programmed cell death
and cancer. Postgrad Med J. 85:134–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ashkenazi A and Herbst RS: To kill a tumor
cell: The potential of proapoptotic receptor agonists. J Clin
Invest. 118:1979–1990. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pérez-Garijo A, Martín FA and Morata G:
Caspase inhibition during apoptosis causes abnormal signalling and
developmental aberrations in Drosophila. Development.
131:5591–5598. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu S, Ye X, Xin W, Xu K, Lian XY and Zhang
Z: Fatsioside A, a rare baccharane-type glycoside inhibiting the
growth of glioma cells from the fruits of fatsia japonica. Planta
Med. 80:315–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Papandreou I, Lim AL, Laderoute K and
Denko N: Hypoxia signals autophagy in tumor cells via AMPK
activity, independent of HIF-1, BNIP3 and BNIP3L. Cell Death
Differ. 15:1572–1581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laderoute KR, Amin K, Calaoagan JM, Knapp
M, Le T, Orduna J, Foretz M and Viollet B: 5-AMP-activated protein
kinase (AMPK) is induced by low-oxygen and glucose deprivation
conditions found in solid-tumor microenvironments. Mol Cell Biol.
26:5336–5347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schulz E, Anter E, Zou MH and Keaney JF
Jr: Estradiol-mediated endothelial nitric oxide synthase
association with heat shock protein 90 requires adenosine
monophosphate-dependent protein kinase. Circulation. 111:3473–3480.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ceolotto G, Gallo A, Papparella I, Franco
L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A
and Avogaro A: Rosiglitazone reduces glucose-induced oxidative
stress mediated by NAD (P) H oxidase via AMPK-dependent mechanism.
Arterioscl Throm Vasc Biol. 27:2627–2633. 2007. View Article : Google Scholar
|
|
15
|
Horie T, Ono K, Nagao K, Nishi H,
Kinoshita M, Kawamura T, Wada H, Shimatsu A, Kita T and Hasegawa K:
Oxidative stress induces GLUT4 translocation by activation of
PI3K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol.
215:733–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jorgensen SB and Rose AJ: How is AMPK
activity regulated in skeletal muscles during exercise? Front
Biosci. 13:5589–5604. 2007.
|
|
17
|
Jones RG, Plas DR, Kubek S, Buzzai M, Mu
J, Xu Y, Birnbaum MJ and Thompson CB: AMP-activated protein kinase
induces a p53-dependent metabolic checkpoint. Mol Cell. 18:283–293.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hwang JT, Ha J, Park IJ, Lee SK, Baik HW,
Kim YM and Park OJ: Apoptotic effect of EGCG in HT-29 colon cancer
cells via AMPK signal pathway. Cancer Lett. 247:115–121. 2007.
View Article : Google Scholar
|
|
19
|
Hwang JT, Ha J and Park OJ: Combination of
5-fluorouracil and genistein induces apoptosis synergistically in
chemo-resistant cancer cells through the modulation of AMPK and
COX-2 signaling pathways. Biochem Bioph Res Commun. 332:433–440.
2005. View Article : Google Scholar
|
|
20
|
Shaw RJ, Kosmatka M, Bardeesy N, Hurley
RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor
LKB1 kinase directly activates AMP-activated kinase and regulates
apoptosis in response to energy stress. Proc Natl Acad Sci USA.
101:3329–3335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sid B, Glorieux C, Valenzuela M,
Rommelaere G, Najimi M, Dejeans N, Renard P, Verrax J and Calderon
PB: AICAR induces Nrf2 activation by an AMPK-independent mechanism
in hepato-carcinoma cells. Biochem Pharmacol. 91:168–180. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Q, Liu X, Zheng X, Yao Y, Wang M and
Liu Q: The transcriptional activity of Gli1 is negatively regulated
by AMPK through Hedgehog partial agonism in hepatocellular
carcinoma. Int J Mol Med. 34:733–741. 2014.PubMed/NCBI
|
|
23
|
Cheng J, Huang T, Li Y, Guo Y, Zhu Y, Wang
Q, Tan X, Chen W, Zhang Y, Cheng W, et al: AMP-activated protein
kinase suppresses the in vitro and in vivo proliferation of
hepatocellular carcinoma. PLoS One. 9:e932562014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnson JJ: Carnosol: A promising
anti-cancer and anti-inflammatory agent. Cancer Lett. 305:1–7.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim T, Davis J, Zhang AJ, He X and Mathews
ST: Curcumin activates AMPK and suppresses gluconeogenic gene
expression in hepatoma cells. Biochem Biophys Res Commun.
388:377–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
HemaIswarya S and Doble M: Potential
synergism of natural products in the treatment of cancer. Phytother
Res. 20:239–249. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chiu YL, Ali A, Chu CY, Cao H and Rana TM:
Visualizing a correlation between siRNA localization, cellular
uptake, and RNAi in living cells. Chem Biol. 11:1165–1175. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bruix J and Sherman M; Practice Guidelines
Committee; American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Skulachev V: Bioenergetic aspects of
apoptosis, necrosis and mitoptosis. Apoptosis. 11:473–485. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hunter AM, LaCasse EC and Korneluk RG: The
inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis.
12:1543–1568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Plumas J, Chaperot L, Richard MJ, Molens
JP, Bensa JC and Favrot MC: Mesenchymal stem cells induce apoptosis
of activated T cells. Leukemia. 19:1597–1604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fesik SW: Promoting apoptosis as a
strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Motoshima H, Goldstein BJ, Igata M and
Araki E: AMPK and cell proliferation-AMPK as a therapeutic target
for atherosclerosis and cancer. J Physiol. 574:63–71. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee YM, Uhm KO, Lee ES, Kwon J, Park SH
and Kim HS: AM251 suppresses the viability of HepG2 cells through
the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal
kinase)-ATF3 (activating transcription factor 3) pathway. Biochem
Bioph Res Commun. 370:641–645. 2008. View Article : Google Scholar
|
|
38
|
Duan X, Ponomareva L, Veeranki S and
Choubey D: IFI16 induction by glucose restriction in human
fibroblasts contributes to autophagy through activation of the
ATM/AMPK/p53 pathway. Plos One. 6:e195322011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sugiyama M, Takahashi H, Hosono K, Endo H,
Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, et al:
Adiponectin inhibits colorectal cancer cell growth through the
AMPK/mTOR pathway. Int J Oncol. 34:339–344. 2009.PubMed/NCBI
|
|
40
|
Rocha GZ, Dias MM, Ropelle ER,
Osório-Costa F, Rossato FA, Vercesi AE, Saad MJ and Carvalheira JB:
Metformin amplifies chemotherapy-induced AMPK activation and
antitumoral growth. Clin Cancer Res. 17:3993–4005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang WB, Wang Z, Shu F, Jin YH, Liu HY,
Wang QJ and Yang Y: Activation of AMP-activated protein kinase by
temozolomide contributes to apoptosis in glioblastoma cells via p53
activation and mTORC1 inhibition. J Biol Chem. 285:40461–40471.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hwang JT, Kwak DW, Lin SK, Kim HM, Kim YM
and Park OJ: Resveratrol induces apoptosis in chemoresistant cancer
cells via modulation of AMPK signaling pathway. Ann NY Acad Sci.
1095:441–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim YM, Hwang JT, Kwak DW, Lee YK and Park
OJ: Involvement of AMPK signaling cascade in capsaicin-induced
apoptosis of ht-29 colon cancer cells. Ann NY Acad Sci.
1095:496–503. 2007. View Article : Google Scholar : PubMed/NCBI
|
